![](https://nocamels.com/wp-content/uploads/2023/05/jab-shoulder-pexels-350x172.jpg)
Slow-Release Jab Set To Transform Schizophrenia Treatment
A revolutionary schizophrenia treatment developed in Israel, which makes it easier for adult patients to manage their illness, has been granted approval by the US Food and Drug Administration, clearing the way for it to reach Americans in need as soon as this month. Pharmaceutical companies Teva of Israel and Medincell of France have teamed […]
May 15, 2023
![AION Labs](https://nocamels.com/wp-content/uploads/2021/10/AIOB_LABS-_-2021-_-by-Elad-Malka_2-350x233.jpg)
Biotech Innovation Lab Harnesses Power Of AI For Drug Development In Israel
AION Labs, is a first-of-its-kind innovation lab spearheading the adoption of AI technologies and computational science
October 17, 2021
![Teva Pharmaceuticals' global headquarters in Petah Tikva, Israel. Photo: Sivan Farag](https://nocamels.com/wp-content/uploads/2020/03/teva1-1-350x193.jpg)
Teva, Technion To Collaborate On Cancer, Neurobiology Research
Israel’s Teva is partnering with the Technion for research into new immunotherapy methods to treat cancer and nervous system diseases.
August 03, 2020
![Pictured right to left: Dr. Dana Bar-On, Teva Academy project lead; David Wilson, Head of Discovery at Teva R&D; Dr. Steffen Nock, SVP, Global Biologics, Teva R&D; Prof. Ariel Porat, President of Tel Aviv University; Prof. Ronit Satchi-Fainaro, Teva Board of Directors; Prof. Yoav Hanis, VP R&D, Tel Aviv University. Photo: Chen Glili](https://nocamels.com/wp-content/uploads/2019/11/Teva-TAU_signing_photo_credit_Chen_Glili-e1574754246978-350x185.jpg)
Teva Teams Up With TAU, Weizmann Institute For Early-Stage Cancer Drug Research
The Israeli pharmaceutical giant signed separate agreements with the universities for innovative drug research and development with a focus on cancer treatments.
November 26, 2019
![Teva pharmaceuticals office in Markham, Ontario](https://nocamels.com/wp-content/uploads/2018/08/1200px-TevaCanada2-350x232.jpg)
FDA Grants Approval For Teva’s Generic Nasal Spray For Opioid Overdoses
Teva's is the first generic naloxone hydrochloride nasal spray approved by the FDA.
April 21, 2019
![Teva pharmaceuticals office in Markham, Ontario](https://nocamels.com/wp-content/uploads/2018/08/1200px-TevaCanada2-350x232.jpg)
Teva’s Generic EpiPen Gets Green Light For US Market
The Israel-based company's generic alternative for US sufferers of anaphylaxis comes two years after Mylan raised the price of its branded drug EpiPen to $600.
August 20, 2018